Washington, D.C. 20549







Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 20, 2016




(Exact name of registrant as specified in its charter)




Delaware   001-34504   20-5340172

(State or other jurisdiction

of incorporation)



File Number)


(IRS Employer

Identification Number)


2300 Warrenville Rd.

Downers Grove, IL

(Address of principal executive offices)   (Zip Code)


(Registrant’s telephone number, including area code)


(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Item 7.01. Regulation FD Disclosure

On January 20, 2016, Addus HomeCare Corporation (the “Company”) was served with a lawsuit that was filed in the United States District Court for the Northern District of Illinois against the Company and Cigna Corporation by Stop Illinois Marketing Fraud, LLC, a qui tam relator formed for the purpose of bringing this action. In the action, the plaintiff alleges, inter alia, violations of the False Claims Act by the Company relating primarily to allegations of improper referrals of patients from our home care division to our home health division, which was sold in 2013. The plaintiff seeks to recover damages, fees and costs under the False Claims Act, including treble damages, civil penalties and its attorneys’ fees. The U.S. government has declined to intervene at this time. Based on its review of the complaint, the Company believes the case will not have a material adverse effect on its business, financial condition or results of operations. The Company intends to defend the litigation vigorously.

Forward-Looking Statements

Certain matters discussed herein constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as “believe,” “intend,” “expect” and similar expressions. These forward-looking statements are based on the Company’s current expectations and beliefs concerning future developments and their potential effect on it. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including the inherent uncertainties involved in litigation, and other risks set forth in the Risk Factors section in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 16, 2015 and its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2015, each of which is available at http://www.sec.gov. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties and other factors. Accordingly, any forward-looking statements included herein do not purport to be predictions of future events or circumstances and may not be realized.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: February 9, 2016     By:   /s/ Donald Klink
    Name:   Donald Klink
    Title:   Chief Financial Officer